Abstract The prevalence of multiple sexual partners (MSPs) remains high worldwide, with sub-Saharan Africa reporting some of ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the ...
Patient preferences key to weighing benefits and risks of indefinite treatment Determining the optimal duration of ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Childhood hypertension affects a substantial and growing proportion of the global paediatric population, with prevalence ...